The rising availability of the drug for sale is creating major concerns among medical experts. Unregulated distributors are proliferating online, supplying the GLP-1 agonist at reduced prices, often without proper clinical assessment or supervision. This practice poses a substantial risk of adverse health effects and fosters unsafe use of a comp… Read More